May 29, 2024 – Page 10 – Goldea Capital

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

Written by Customer Service on May 29, 2024. Posted in Earnings Releases And Operating Results.

NexoBrid® interest surges; $5 million in Q1 2024 revenue, with $24 million forecast for the year Manufacturing facility on target for completion by mid-2024 EscharEx® Phase III study to launch 2H 2024 Company set to join Russell 3000® Index Conference call today, May 29 at 8:30am Eastern Time YAVNE, Israel, May 29, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2024, and provided a corporate update. “During the first quarter we maintained a laser-focused approach to executing our strategic plan. At the beginning of the year, we set three major goals: accelerate the revenue growth of NexoBrid®, complete construction of the new manufacturing facility by mid-year, and...

Lotus Technology Reports Unaudited First Quarter 2024 Financial Results

Written by Customer Service on May 29, 2024. Posted in Earnings Releases And Operating Results.

Lotus Tech recorded revenue of $173 million and gross profit margin of 18% Delivered approximately 2,194 vehicles1, with global markets outside China contributing over 75% of total deliveries Revealed luxury customized editions of classic sportscar and BEV lifestyle models NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global luxury electric vehicle maker, today announced its unaudited financial results for the first quarter ended March 31, 2024. The Company achieved total revenue of $173 million in the quarter, a year-on-year growth of 811% and a gross profit margin of 18%, powered by an asset-light model and high-margin businesses including R&D services and accessories. The Company successfully launched its Chapman Bespoke...

Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024

Written by Customer Service on May 29, 2024. Posted in Earnings Releases And Operating Results.

Reduces operating expenses by 34% and net loss by 64% DURHAM, N.C., May 29, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX) (‘Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today provided strategic, financial, and operational updates for the first quarter ended March 31, 2024. Jeff Wolf, CEO of Scorpius Holdings, Inc., stated, “We are successfully executing our strategy to enhance revenue and reduce costs as we seek to become cash flow positive in the near future. This quarter is indicative of this goal as we achieved a 359% increase in revenue while reducing operating expenses by 34% over the same period last year. We believe this performance reinforces the growing demand for our services and our prudent financial management. Moreover, we have built...

Howard Hughes Holdings Inc. to Present at NAREIT REITweek 2024 Investor Conference

Written by Customer Service on May 29, 2024. Posted in Public Companies.

Presentation and Live Webcast to be Held June 4, 2024, at 10:15 am ET THE WOODLANDS, Texas, May 29, 2024 (GLOBE NEWSWIRE) — Howard Hughes Holdings Inc. (NYSE: HHH) announced today that Chief Financial Officer Carlos Olea will participate in a presentation moderated by Alex Goldfarb from Piper Sandler at NAREIT’s REITweek 2024 Investor Conference in New York City on Tuesday, June 4, 2024, at 10:15 am ET. HHH’s live presentation will be accessible via audio webcast using the link below. Upon completion of the presentation, an on-demand replay will be available for a period of 30 days. Howard Hughes Holdings Inc. PresentationDate: Tuesday, June 4, 2024Time: 10:15 am ETAudio Webcast Link: https://vimeo.com/event/4280082/ About Howard Hughes Holdings Inc.Howard Hughes Holdings Inc. owns, manages, and develops commercial,...

Ocugen to Present at BIO International Convention 2024

Written by Customer Service on May 29, 2024. Posted in Public Companies.

MALVERN, Pa., May 29, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company will present at the 2024 BIO International Convention taking place in San Diego, CA from June 3 – 6, 2024. During the conference, Ocugen’s leadership team will host meetings with potential partners and pharmaceutical executives to explore opportunities for the Company’s dynamic pipeline addressing unmet medical needs—particularly its first-in-class ophthalmic modifier gene therapy and regenerative cell therapy platforms. “We are excited to return to BIO this year and showcase the significant advancements we’ve achieved both clinically and strategically,” said Dr. Shankar...

Draganfly to Present at Centurion One Los Angeles Summit 2024

Written by Customer Service on May 29, 2024. Posted in Public Companies.

CEO Cameron Chell to Highlight the Role of Drones and Draganfly in the New Global Economic and Political Reality Los Angeles, CA, May 29, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A), a leader in drone technology and unmanned aerial vehicle (UAV) solutions, will be participating in the Centurion One Los Angeles Summit, held at the Beverly Hills Hotel from June 5th to June 6th, 2024, in Beverly Hills, California. The Centurion One Los Angeles Summit is an event that brings together industry-leading companies along with thought-provoking expert panels. Following the success of the 2023 Los Angeles Summit, the 2024 event will feature both public and private companies from different industries presenting to an audience of retail, venture capital, family office, private equity firms, high-net-worth individuals,...

Red Pine Intercepts Significant Mineralization at the Wawa Gold Project, including 5.58 g/t gold over 18.44 m including 72.20 g/t gold over 0.88 m

Written by Customer Service on May 29, 2024. Posted in Public Companies.

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) is pleased to announce the most recent assay results from 14 drill holes representing 4,105 metres (“m”) of drilling from the 2022-2024 resource expansion program at the Wawa Gold Project. Since the resource expansion drilling program began in 2021, Red Pine has now completed approximately 67,000 m of additional drilling in the current program for the new mineral resource estimate update. Of these holes, approximately 60,300 m have now been reported and the Company expects additional results to follow over the coming months from the remaining core. Drilling Highlights (Table 1, Figures 1-3): 5.58 grams per tonne (“g/t”) gold over 18.44 m, including 6.18 g/t gold over 1.11 m, and 72.20 g/t gold over 0.88 m...

Castellum, Inc. Announces Leadership Changes

Written by Customer Service on May 29, 2024. Posted in Public Companies.

Castellum, Inc. Announces Leadership Changes Mark Fuller, co-founder of Castellum and Chief Executive Officer (“CEO”), will be stepping down as CEO effective July 1, 2024, to pursue other interests. Glen Ives, currently Chief Operating Officer of Castellum, will become the new CEO, effective July 1, 2024 – http://castellumus.com VIENNA, Va., May 29, 2024 (GLOBE NEWSWIRE) — Castellum, Inc. (the “Company” or “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces two leadership changes. Mark Fuller, co-founder of Castellum and Chief Executive Officer (“CEO”), will be stepping down as CEO effective July 1, 2024, to pursue other interests. Glen Ives, currently Chief Operating Officer of Castellum, will become the new CEO, effective...

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides

Written by Customer Service on May 29, 2024. Posted in Public Companies.

Opportunity for Iopofosine Expansion Within Areas of High Unmet Need in Non-Hodgkin’s Lymphoma Establishes Partnership With One of the Largest Cancer Research and Treatment Organizations in the U.S. FLORHAM PARK, N.J., May 29, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, announced today a strategic partnership with City of Hope Cancer Center, one of the largest cancer research and treatment organizations in the United States. The collaboration will focus on the clinical development of Cellectar’s lead radioconjugate asset, iopofosine I 131, in mycosis fungoides (MF), a rare form of non-Hodgkin’s lymphoma (NHL) that affects the skin and, in some patients,...

Kraken Robotics Reports Record Q1 2024 Financial Results

Written by Customer Service on May 29, 2024. Posted in Earnings Releases And Operating Results.

Revenue increased 175% to $21 million, Adjusted EBITDA increased 354% to $4 million ST. JOHN’S, Newfoundland and Labrador, May 29, 2024 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF) (“Kraken” or the “Company”), announced it has filed its financial results for the quarter ended March 31, 2024 (“Q1 2024”). Please refer to the unaudited Consolidated Financial Statements and Management’s Discussion and Analysis (“MD&A”) for quarter ended March 31, 2024, filed on www.sedarplus.ca for more information. Unless otherwise specified, all dollar amounts are denominated in Canadian dollars. Q1 2024 Financial Highlights Consolidated revenue for Q1 2024 was $20.9 million compared to $7.6 million, an increase of 175% over the comparable quarter. Revenue mix was 76% Product / 24% Service. Product...

Day: May 29, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice